| Molecular programming of B cell memory M McHeyzer-Williams, S Okitsu, N Wang, L McHeyzer-Williams Nature Reviews Immunology 12 (1), 24-34, 2012 | 588 | 2012 |
| Class-switched memory B cells remodel BCRs within secondary germinal centers LJ McHeyzer-Williams, PJ Milpied, SL Okitsu, MG McHeyzer-Williams Nature immunology 16 (3), 296-305, 2015 | 269 | 2015 |
| Divergent transcriptional programming of class-specific B cell memory by T-bet and RORα NS Wang, LJ McHeyzer-Williams, SL Okitsu, TP Burris, SL Reiner, ... Nature immunology 13 (6), 604-611, 2012 | 200 | 2012 |
| High-throughput assay and discovery of small molecules that interrupt malaria transmission DM Plouffe, M Wree, AY Du, S Meister, F Li, K Patra, A Lubar, SL Okitsu, ... Cell host & microbe 19 (1), 114-126, 2016 | 165 | 2016 |
| Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial FM Thompson, DW Porter, SL Okitsu, N Westerfeld, D Vogel, S Todryk, ... PLoS One 3 (1), e1493, 2008 | 131 | 2008 |
| TLR7 and TLR8 differentially activate the IRF and NF-κB pathways in specific cell types to promote inflammation AT Bender, E Tzvetkov, A Pereira, Y Wu, S Kasar, MM Przetak, J Vlach, ... Immunohorizons 4 (2), 93-107, 2020 | 80 | 2020 |
| A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers B Genton, G Pluschke, L Degen, AR Kammer, N Westerfeld, SL Okitsu, ... PloS one 2 (10), e1018, 2007 | 72 | 2007 |
| Btk inhibition treats TLR7/IFN driven murine lupus AT Bender, A Pereira, K Fu, E Samy, Y Wu, L Liu-Bujalski, R Caldwell, ... Clinical immunology 164, 65-77, 2016 | 61 | 2016 |
| A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial SL Okitsu, O Silvie, N Westerfeld, M Curcic, AR Kammer, MS Mueller, ... PloS one 2 (12), e1278, 2007 | 60 | 2007 |
| Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation SL Okitsu, U Kienzl, K Moehle, O Silvie, E Peduzzi, MS Mueller, ... Chemistry & Biology 14 (5), 577-587, 2007 | 48 | 2007 |
| Discovery of M5049: a novel selective toll-like receptor 7/8 inhibitor for treatment of autoimmunity J Vlach, AT Bender, M Przetak, A Pereira, A Deshpande, TL Johnson, ... Journal of Pharmacology and Experimental Therapeutics 376 (3), 397-409, 2021 | 43 | 2021 |
| Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and … SL Okitsu, F Boato, MS Mueller, DB Li, D Vogel, N Westerfeld, ... Peptides 28 (10), 2051-2060, 2007 | 29 | 2007 |
| Antibody and T‐cell responses associated with experimental human malaria infection or vaccination show limited relationships KM Walker, S Okitsu, DW Porter, C Duncan, M Amacker, G Pluschke, ... Immunology 145 (1), 71-81, 2015 | 27 | 2015 |
| Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology SL Okitsu, MS Mueller, M Amacker, D Vogel, N Westerfeld, JA Robinson, ... Human Vaccines 4 (2), 106-114, 2008 | 14 | 2008 |
| ATX-MS-1467 induces long-term tolerance to myelin basic protein in (DR2× Ob1) F1 mice by induction of IL-10-secreting iTregs ALS De Souza, S Rudin, R Chang, K Mitchell, T Crandall, S Huang, ... Neurology and Therapy 7, 103-128, 2018 | 11 | 2018 |
| Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis H Ding, Y Shen, C Lin, L Qin, S He, M Dai, SL Okitsu, JA DeMartino, ... Arthritis Research & Therapy 24 (1), 77, 2022 | 5 | 2022 |
| Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases T Clarke, P Du, S Kumar, SL Okitsu, M Schuette, Q An, J Zhang, ... Frontiers in Immunology 14, 1106537, 2023 | 4 | 2023 |
| Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus F Faustini, H Idborg, E Fuzzi, A Larsson, WR Lie, S Pötzsch, SL Okitsu, ... Lupus 32 (2), 252-262, 2023 | 2 | 2023 |
| O37 M5049, a novel potent and selective inhibitor of toll-like receptors 7 and 8 (TLR 7/8) B Sherer, AT Bender, A Pereira, S Reissig, P Haselmayer, SL Okitsu, ... Lupus Science & Medicine 7 (Suppl 1), 2020 | 2 | 2020 |
| Failure of in vitro differentiation of Plasmodium falciparum gametocytes into ookinetes arises because of poor gamete fertilisation MJ Delves, SR Marques, A Ruecker, U Straschil, C Miguel-Blanco, ... bioRxiv, 216721, 2017 | 2 | 2017 |
